Our Latest News and Events

Patient’s generous legacy funds new state-of-the-art lab facilities

.

Today sees the launch of our state-of-the-art research facility thanks to a generous legacy left by a patient.

In 2014, former ROH patient, Mr Michael Dubrowsky passed away and left a significant legacy gift to the ROH Charitable Fund following treatment he received here for chondrosarcoma. This generous gift has enabled us to invest in a new state of the art regenerative medicine laboratory onsite - The Dubrowsky Regenerative Medicine Laboratory. Located close to theatres on the main ROH estate, the lab will have a focus on chondrosarcoma and cartilage research, and will enable ROH to continue to lead the scientific community in the development of understanding and treatments for this rare disease.

The laboratory was officially launched on 17 December 2019 by Dame Yve Buckland, Chair of The Royal Orthopaedic Hospital, in a ceremony which had representation from ROH colleagues, research partners, patients and well-wishers. Speakers included Professor Philip Begg, ROH Director of Strategy and Delivery; Mr Adrian Gardener, ROH Director of Research and Development and Consultant Surgeon; Dame Yve Buckland and Mr. Dubrowsky’s close friend, Anne Brookes.

What does the launch of the Dubrowsky Regenerative Medicine Laboratory mean for ROH?

  • Having our own fully equipped laboratory will give ROH a degree of impact within the Birmingham medical science community beyond anything we have had before.
  • ROH clinical researchers and support staff will have brand new facilities that showcase the hospital as a serious research partner, increasing opportunities for researchers to engage with each other and to encourage new partnerships.
  • The lab will give ROH an opportunity to foster international collaboration in the field of chondrosarcoma.

Professor Phil Begg, Executive Director of Strategy said: “This new laboratory will enable our Trust to conduct even more ground-breaking research in to rare cancers and orthopaedic treatments. The legacy of Michael Dubrowsky is monumental and will have an impact for many years to come.”

The Royal Orthopaedic Hospital is one of the largest specialist orthopaedic units in Europe, performing around 3,000 hip and knee replacements each year. The hospital ranks among the highest in the NHS for patient experience with a 96% recommendation rating from patients.